Sally-Ann Poulsen
From Wikipedia, the free encyclopedia
University of Cambridge
AstraZeneca
Sally-Ann Poulsen | |
|---|---|
| Alma mater | Griffith University |
| Scientific career | |
| Institutions | Griffith University University of Cambridge AstraZeneca |
| Thesis | Pyrazolo 3,4-d pyrimidines : synthesis and structure-activity relationships for binding to adenosine receptors (1996) |
Sally-Ann Poulsen is an Australian chemical biologist who is a Professor and Director at Griffith University. Her research considers medicinal chemistry and drug discovery. She is Chair of the Royal Australian Chemical Institute Medicinal Chemistry and Chemical Biology Division.
Poulsen grew up in a rural community in Australia. She attended a small primary school of only seventeen students and one teacher. She was the highest achieving student of her school.[citation needed] After completing high school, Poulsen got a job, and eventually decided to go to university. Poulsen was an undergraduate student at Griffith University, where she was a university medallist.[citation needed] She was the first member of her family to complete higher education. During her bachelor's degree she started to study pyrazolo [3,4-d] pyrimidines.[1] As an undergraduate student, Poulsen was part of the National Youth Science Forum.[2] Poulsen remained at Griffith University for her graduate studies, where she continued to study pyrimidines, looking for structure-function relationships in their binding to adenosine receptors.[1][3] After earning her doctorate, Poulsen moved to the United Kingdom, where she was a postdoctoral researcher at the University of Cambridge and AstraZeneca. She proposed that adenosine receptors offered novel opportunities of drug design.[citation needed]
